What are the recommended treatment options for managing ingrown toenails, particularly in patients with a history of diabetes or impaired circulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Ingrown Toenails

In patients with diabetes or impaired circulation, ingrown toenails must be treated by trained healthcare professionals rather than through self-care, with treatment frequency every 1-3 months for high-risk patients to prevent progression to ulceration. 1

Risk Stratification in Diabetic Patients

Before treating an ingrown toenail in a diabetic patient, assess their ulceration risk using the IWGDF system:

  • Screen for peripheral neuropathy using 10g Semmes-Weinstein monofilament testing and assess for peripheral artery disease by checking pedal pulses 1, 2
  • Classify risk level: Patients with loss of protective sensation or PAD are automatically at increased risk (IWGDF risk 1-3) 1
  • Ingrown toenails in diabetic patients with neuropathy or PAD are considered pre-ulcerative lesions requiring immediate professional intervention 3, 2

Treatment Algorithm by Patient Population

For Diabetic or Vascular Compromise Patients (High Priority)

Conservative Management (First-Line):

  • Professional nail care only—never allow self-treatment or use of chemical agents 3
  • Trained healthcare professionals should perform proper nail trimming (cut straight across) and remove any associated callus 1
  • Schedule regular professional foot care every 1-3 months for high-risk patients (IWGDF risk 3) or every 3-6 months for moderate-risk patients (IWGDF risk 2) 1, 3
  • Prescribe extra-depth shoes with wide toe-box to reduce pressure on affected toes 3, 2
  • Educate patients to inspect feet daily and immediately contact healthcare professionals if inflammation or drainage develops 1

Surgical Intervention (When Conservative Fails):

  • Digital flexor tenotomy is the preferred surgical approach for diabetic patients with flexible hammertoes and ingrown nails with pre-ulcerative signs, achieving 92-100% healing rates in 21-40 days 3, 2
  • This outpatient procedure requires no subsequent immobilization and has recurrence rates of only 0-20% over 11-36 months 3, 2
  • Important caveat: Post-operative infection risk is 9.5% in diabetic neuropathy patients, requiring careful patient selection 3, 2

For Non-Diabetic Patients Without Vascular Compromise

Stage 1 (Mild): Erythema, slight edema, pain with pressure

  • Soak foot in warm, soapy water 4, 5
  • Place cotton wisps or dental floss under the ingrown nail edge to elevate it 4, 5, 6
  • Apply gutter splint to separate nail from lateral fold for immediate pain relief 6
  • Correct improper footwear and nail-trimming technique 4, 5
  • Apply mid- to high-potency topical steroid after soaking 6

Stage 2 (Moderate): Worsening symptoms, drainage, infection

  • Continue conservative measures or proceed to surgical intervention 4
  • Consider oral antibiotics if cellulitis is present, though antibiotics do not improve outcomes when combined with phenolization 5
  • Gutter splinting or cotton nail cast with cyanoacrylate adhesive may provide relief 6

Stage 3 (Severe): Lateral wall hypertrophy, granulation tissue

  • Partial nail avulsion with lateral matricectomy is the definitive treatment 4, 5, 6
  • Chemical matricectomy with phenol is highly effective and prevents recurrence better than surgical excision alone, though it carries slightly increased infection risk 5, 6
  • Electrosurgical matricectomy offers more controlled tissue destruction and less postoperative drainage compared to phenol 4
  • Complete nail excision is rarely necessary and has higher recurrence rates 5

Critical Pitfalls to Avoid

  • Never allow diabetic patients to perform self-treatment of ingrown toenails, as they lack protective sensation and cannot detect early infection 3
  • Do not delay professional treatment in diabetic patients—ingrown nails are pre-ulcerative lesions that can rapidly progress to ulceration 3, 2
  • Avoid narrow or tight footwear that increases pressure on affected toes, particularly in diabetic patients 1, 2
  • Do not use oral antibiotics routinely before or after phenolization, as they do not improve outcomes 5
  • Screen for hyperhidrosis and onychomycosis, as these contribute to ingrown nail development and must be managed concurrently 5, 6

Prevention Strategies

  • Educate all at-risk patients to cut toenails straight across rather than curved 1
  • Daily foot inspection is mandatory for diabetic patients to detect early signs of ingrown nails 1
  • Wear properly fitting footwear that accommodates foot shape, with shoe length 1-2 cm longer than the foot 2
  • Apply emollients daily to maintain skin elasticity and prevent nail problems 1
  • Never walk barefoot or in thin-soled slippers, whether indoors or outdoors 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Hammer Toe in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Ingrown Toenails and Pre-Ulcerative Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Management of ingrown toenails.

American family physician, 1995

Research

Management of the ingrown toenail.

American family physician, 2009

Research

Ingrown Toenail Management.

American family physician, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.